These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 903326)

  • 1. The action of trimethoprim and rifampicin in combination against Gram-negative rods resistant to gentamicin.
    Farrell W; Wilks M; Drasar FA
    J Antimicrob Chemother; 1977 Sep; 3(5):459-62. PubMed ID: 903326
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro susceptibility of gram-negative bacilli to gentamicin.
    Washington JA; Ritts RE; Martin WJ
    Mayo Clin Proc; 1970 Feb; 45(2):146-9. PubMed ID: 4984183
    [No Abstract]   [Full Text] [Related]  

  • 3. Trimethoprim and rifampicin: in vitro activities separately and in combination.
    Kerry DW; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1975 Dec; 1(4):417-27. PubMed ID: 1206027
    [No Abstract]   [Full Text] [Related]  

  • 4. The interaction of trimethoprim and quinolones against gram-negative fish pathogens.
    Inglis V; Cafini M; Yoshida T
    J Appl Bacteriol; 1995 Aug; 79(2):135-40. PubMed ID: 7592108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of rifampin and trimethoprim in vitro.
    Alvarez S; DeMaria A; Kulkarni R; Klein JO; McCabe WR
    Rev Infect Dis; 1982; 4(2):390-401. PubMed ID: 7111962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between rifampicin and trimethoprim in vitro and in experimental infections.
    Arioli V; Berti M; Carniti G; Rossi E
    J Antimicrob Chemother; 1977 Jan; 3(1):87-94. PubMed ID: 321415
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility of obligate anaerobes to trimethoprim-sulfamethoxazole.
    Indiveri MC; Hirsh DC
    J Am Vet Med Assoc; 1986 Jan; 188(1):46-8. PubMed ID: 3484737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal action of amoxycillin alone and in combination with gentamicin and rifampicin against Brucella melitensis.
    Gwynn MN; Rolinson GN
    J Infect; 1980 Mar; 2(1):61-5. PubMed ID: 7185916
    [No Abstract]   [Full Text] [Related]  

  • 9. The interactions between rifampicin and trimethoprim: an in vitro study.
    Grüneberg RN; Emmerson AM
    J Antimicrob Chemother; 1977 Sep; 3(5):453-7. PubMed ID: 409709
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia.
    Yu VL; Felegie TP; Yee RB; Pasculle AW; Taylor FH
    J Infect Dis; 1980 Oct; 142(4):602-7. PubMed ID: 7441019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of transferable trimethoprim and gentamicin resistance plasmids in Enterobacteriaceae].
    Tschäpe H; Bratoeva M; Heier H; Tietze E; Ziesché K; Rishce H
    Z Allg Mikrobiol; 1981; 21(8):611-21. PubMed ID: 6277092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of genes for trimethoprim and gentamicin resistance in bacteria and their plasmids in a general hospital.
    Datta N; Dacey S; Hughes V; Knight S; Richards H; Williams G; Casewell M; Shannon KP
    J Gen Microbiol; 1980 Jun; 118(2):495-508. PubMed ID: 7003059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance patterns of certain Enterobacteriaceae in hospital and outpatients, with particular reference to trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V
    MMW Munch Med Wochenschr; 1976 Feb; 118(9):275-8. PubMed ID: 817195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of nonfermentative gram-negative bacilli to tobramycin.
    Uwaydah M; Taqi-Eddin AR
    J Infect Dis; 1976 Aug; 134 Suppl():S28-32. PubMed ID: 823278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of cefoxitin compared with the activity of other antibiotics and trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V
    Med Klin; 1978 Mar; 73(12):423-7. PubMed ID: 347234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of emergence of bacterial resistance by combination of two antibiotics: rifampicin and trimethoprim.
    Grüneberg RN; Emmerson AM
    J Antimicrob Chemother; 1980 May; 6(3):349-56. PubMed ID: 6995419
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
    J Clin Pathol; 1981 May; 34(5):559-63. PubMed ID: 6910479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
    Zemelman R; González C; Mondaca MA
    Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
    [No Abstract]   [Full Text] [Related]  

  • 19. In-vitro sensitivity of Elavobacterium meningosepticum to antimicrobial agents.
    Altmann G; Bogokovsky B
    J Med Microbiol; 1971 May; 4(2):296-9. PubMed ID: 4105616
    [No Abstract]   [Full Text] [Related]  

  • 20. In-vitro bactericidal synergism of rifampicin and trimethoprim and implications for treatment of carriers of Haemophilus influenzae.
    McDougal LK; Thornsberry C
    J Antimicrob Chemother; 1982 May; 9(5):369-78. PubMed ID: 6980217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.